This study is currently not recruiting participants.

Comparative Effectiveness Research Trial of Alzheimer's Disease Drug (COMET-AD)

Study on Medication Adherence and Side Effects

Not Recruiting
18 years - 100 years
All
Phase N/A

Brief description of study.

The purpose of this study is to learn about drug adherence or how patients take medications and the side effects patients experience when taking these medications.

Detailed description of study

The purpose of this study is to learn about drug adherence or how patients take medications and the side effects patients experience when taking these medications.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Alzheimer's Disease
  • Age: 18 years - 100 years
  • Gender: All

The purpose of this study is to learn about drug adherence, which means how patients take their medications. It also looks at the side effects that patients experience when taking these medications.

Participants in this study will be asked to report how they take their medications and any side effects they notice. This information will help researchers understand medication adherence and its impact on patients.

  • Who can participate: No specific eligibility criteria are provided. General requirements may include age and health status.
  • Study details: Participants will be required to report their medication-taking habits and any side effects they experience.
Updated on 19 Feb 2024. Study ID: 1105005285

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team